Lefebvre L, Smith M
Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Mol Cell Biol. 1993 Sep;13(9):5393-407. doi: 10.1128/mcb.13.9.5393-5407.1993.
The Saccharomyces cerevisiae SPT2 gene was identified by genetic screens for mutations which are suppressors of Ty and delta insertional mutations at the HIS4 locus. The ability of spt2 mutations to suppress the transcriptional interference caused by the delta promoter insertion his-4-912 delta correlates with an increase in wild-type HIS4 mRNA levels. The SPT2 gene is identical to SIN1, which codes for a factor genetically defined as a negative regulator of HO transcription. Mutations in SPT2/SIN1 suppress the effects of trans-acting mutations in SWI genes and of partial deletions in the C-terminal domain of the largest subunit of RNA polymerase II. Nuclear localization and protein sequence similarities suggested that the SPT2/SIN1 protein may be related to the nonhistone chromosomal protein HMG1. To assess the significance of this structural similarity and identify domains of SPT2 functionally important in the regulation of his4-912 delta, we have studied recessive and dominant spt2 mutations created by in vitro mutagenesis. We show here that several alleles carrying C-terminal deletions as well as point mutations in the C-terminal domain of the SPT2 protein exhibit a dominant suppressor phenotype. C-terminal basic residues necessary for wild-type SPT2 protein function which are absent from HMG1 have been identified. The competence of these mutant SPT2 proteins to interfere with the maintenance of the His- (Spt+) phenotype of a his4-912 delta SPT2+ strain is lost by deletion of internal HMG1-like sequences and is sensitive to the wild-type SPT2+ gene dosage. Using cross-reacting antipeptide polyclonal antibodies, we demonstrate that the intracellular level of the wild-type SPT2 protein is not affected in presence of dominant mutations and furthermore that the reversion of the dominance by internal deletion of HMG1-like sequences is not mediated by altered production or stability of the mutant polypeptides. Our results suggest that the products of dominant alleles directly compete with the wild-type protein. On the basis of primary sequence similarities, we propose that an HMG-box-like motif is required for SPT2 function in vivo and that this motif also is necessary for the dominant suppressor phenotype exhibited by some mutant SPT2 alleles.
酿酒酵母的SPT2基因是通过遗传筛选鉴定出来的,该筛选针对的是HIS4位点上Ty和δ插入突变的抑制子突变。spt2突变抑制由δ启动子插入his-4-912δ引起的转录干扰的能力,与野生型HIS4 mRNA水平的增加相关。SPT2基因与SIN1相同,SIN1编码一种在遗传上被定义为HO转录负调控因子的因子。SPT2/SIN1中的突变抑制了SWI基因中转基因作用突变以及RNA聚合酶II最大亚基C末端结构域部分缺失的影响。核定位和蛋白质序列相似性表明,SPT2/SIN1蛋白可能与非组蛋白染色体蛋白HMG1相关。为了评估这种结构相似性的意义,并确定在调控his4-912δ中功能重要的SPT2结构域,我们研究了通过体外诱变产生的隐性和显性spt2突变。我们在此表明,几个携带C末端缺失以及SPT2蛋白C末端结构域点突变的等位基因表现出显性抑制子表型。已经鉴定出野生型SPT2蛋白功能所必需的C末端碱性残基,而HMG1中不存在这些残基。这些突变的SPT2蛋白干扰his4-912δ SPT2+菌株His-(Spt+)表型维持的能力,会因内部HMG1样序列的缺失而丧失,并且对野生型SPT2+基因剂量敏感。使用交叉反应抗肽多克隆抗体,我们证明在存在显性突变的情况下野生型SPT2蛋白的细胞内水平不受影响,此外,通过内部缺失HMG1样序列使显性恢复,并非由突变多肽产生或稳定性的改变介导。我们的结果表明,显性等位基因的产物直接与野生型蛋白竞争。基于一级序列相似性,我们提出,体内SPT2功能需要一个HMG盒样基序,并且该基序对于一些突变SPT2等位基因表现出的显性抑制子表型也是必需的。